EE233 Cost-Effectiveness of Ravulizumab Compared with Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Netherlands

Verfasser: Quist, S
Postma, AJ
Myren, KJ
de Jong, L
Postma, MJ
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Value in Health ; volume 25, issue 12, page S99 ; ISSN 1098-3015
Verlag/Hrsg.: Elsevier BV
Schlagwörter: Public Health / Environmental and Occupational Health / Health Policy
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27191195
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1016/j.jval.2022.09.481